Change of Name

Recorded: 2016-02-25 Pages: 3

Assignor

IDEC PHARMACEUTICALS CORPORATION

Executed: 2003-11-12

Assignee

BIOGEN IDEC INC.

14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Property (1)

Combination Therapies for B-Cell Lymphomas Comprising Administration of Anti-CD20 Antibody

Application: 14/070,256 →

Publication: US 2014/0056887

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.